ABT : Summary for Abbott Laboratories Common Stoc - Yahoo Finance

U.S. Markets closed

Abbott Laboratories (ABT)


NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
40.46+0.06 (+0.15%)
At close: 4:01PM EST
People also watch
ABBVBMYLLYJNJMRK
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close40.40
Open40.51
Bid0.00 x
Ask0.00 x
Day's Range40.35 - 40.77
52 Week Range36.00 - 45.79
Volume5,907,996
Avg. Volume8,931,695
Market Cap69.84B
Beta1.49
PE Ratio (TTM)26.71
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield1.06 (2.60%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Benzingayesterday

    The Biggest Mergers Currently Stuck In Regulatory Purgatory

    After a meeting with President-elect Donald Trump, Bayer AG (ADR) (OTC: BAYRY ) generated excitement among American investors eager to finalize a long-anticipated merger with Monsanto Company (NYSE: MON ...

  • Barrons.comyesterday

    [$$] Abbott Set for 12% EPS Growth

    Abbott Laboratories (ABT: NYSE) By Wells Fargo Securities ($40.76, Jan. 18, 2017) Following the closing of the St. Jude Medical acquisition on Jan. 4, we have updated our Abbott Laboratories model and ...

  • ACCURATE Study Confirms Superiority Of Abbott Laboratories (ABT) Dorsal Root Ganglion (DRG) Stimulation
    Insider Monkey2 days ago

    ACCURATE Study Confirms Superiority Of Abbott Laboratories (ABT) Dorsal Root Ganglion (DRG) Stimulation

    Abbott Laboratories (NYSE:ABT)‘s dorsal root ganglion (DRG) stimulation therapy has advantages over traditional spinal cord stimulation (SCS) in the treatment of patients suffering from complex regional pain syndrome (CRPS). This is according to the latest data that was published in the January edition of Pain. The publication highlighted the real-world insight both in a short-term […]